Geron 8-K 2012
Documents found in this filing:
Date of Report (Date of earliest event reported): January 11, 2012
230 CONSTITUTION DRIVE
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 7.01 Regulation FD Disclosure.
At 8:00 a.m. PST, Wednesday, January 11, 2012, John A. Scarlett, M.D., President and Chief Executive Officer of Geron Corporation (the Company or Geron), will present at the JPMorgan Global Healthcare Conference in San Francisco, CA. The slides accompanying the presentation, together with a slide setting forth certain cautionary language intended to qualify the forward-looking statements included in the presentation, are furnished as Exhibit 99.1 to this Current Report on Form 8-K and are incorporated herein by reference. The slides will also be made available in the Investor Relations section of Gerons website located at www.geron.com.
The information in this Item 7.01 and Exhibit 99.1 shall be deemed to be furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.